newsfilter
← Latest News
GlobeNewswire·

Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO) a clinical stage company focused on reshaping the path of genetic diseases with high unmet need, today announced that it will host an